CRISPR and CRISPR-associated (Cas) Genes Market Report

Global and China CRISPR and CRISPR-associated (Cas) Genes Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 10, 2022
  • PAGES：223
  • REPORT CODE：GMM1362660
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the CRISPR and CRISPR-associated (Cas) Genes industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • GE Healthcare Dharmacon

    • Intellia Therapeutics

    • Addgene

    • Caribou Biosciences

    • Editas Medicine

    • Takara Bio USA

    • Thermo Fisher Scientific

    • Merck KGaA

    • Mirus Bio LLC

    • CRISPR THERAPEUTICS

    • Horizon Discovery Group

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Genome Editing

    • Genetic Engineering

    • gRNA Database/Gene Librar

    • CRISPR Plasmid

    • Human Stem Cells

    • Genetically Modified Organisms/Crops

    • Cell Line Engineering

    Application:

    • Biotechnology Companies

    • Pharmaceutical Companies

    • Academic Institutes

    • Research and Development Institutes

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 CRISPR and CRISPR-associated (Cas) Genes Industry Overview

      • 1.1.1 CRISPR and CRISPR-associated (Cas) Genes Market Scope and Market Segments

      • 1.1.2 CRISPR and CRISPR-associated (Cas) Genes Industry Characteristics

      • 1.1.3 Global and China CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China CRISPR and CRISPR-associated (Cas) Genes Production Value and Growth Rate (2017-2028)

    • 1.2 Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Genome Editing

      • 1.2.2 Genetic Engineering

      • 1.2.3 gRNA Database/Gene Librar

      • 1.2.4 CRISPR Plasmid

      • 1.2.5 Human Stem Cells

      • 1.2.6 Genetically Modified Organisms/Crops

      • 1.2.7 Cell Line Engineering

    • 1.3 Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Biotechnology Companies

      • 1.3.2 Pharmaceutical Companies

      • 1.3.3 Academic Institutes

      • 1.3.4 Research and Development Institutes

    • 1.4 Market Analysis by Region

      • 1.4.1 North America CRISPR and CRISPR-associated (Cas) Genes Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe CRISPR and CRISPR-associated (Cas) Genes Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC CRISPR and CRISPR-associated (Cas) Genes Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global CRISPR and CRISPR-associated (Cas) Genes Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 CRISPR and CRISPR-associated (Cas) Genes Industry Porter's Five Forces Model Analysis

      • 2.2.3 CRISPR and CRISPR-associated (Cas) Genes Industry PEST Analysis

    • 2.3 CRISPR and CRISPR-associated (Cas) Genes Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 CRISPR and CRISPR-associated (Cas) Genes Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on CRISPR and CRISPR-associated (Cas) Genes Industry

    Chapter 3 Global and China CRISPR and CRISPR-associated (Cas) Genes Market, by Manufacturer

    • 3.1 Global and China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China CRISPR and CRISPR-associated (Cas) Genes Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China CRISPR and CRISPR-associated (Cas) Genes Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China CRISPR and CRISPR-associated (Cas) Genes Market Top 3 Players

    Chapter 4 Global and China CRISPR and CRISPR-associated (Cas) Genes Market, by Type (2017-2028)

    • 4.1 CRISPR and CRISPR-associated (Cas) Genes Market Trend, by Type

    • 4.2 Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global CRISPR and CRISPR-associated (Cas) Genes Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global CRISPR and CRISPR-associated (Cas) Genes Price Trend, by Type (2017-2028)

    • 4.3 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China CRISPR and CRISPR-associated (Cas) Genes Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China CRISPR and CRISPR-associated (Cas) Genes Price Trend, by Type (2017-2028)

    Chapter 5 Global and China CRISPR and CRISPR-associated (Cas) Genes Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global CRISPR and CRISPR-associated (Cas) Genes Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China CRISPR and CRISPR-associated (Cas) Genes Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global CRISPR and CRISPR-associated (Cas) Genes Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China CRISPR and CRISPR-associated (Cas) Genes Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America CRISPR and CRISPR-associated (Cas) Genes Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe CRISPR and CRISPR-associated (Cas) Genes Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC CRISPR and CRISPR-associated (Cas) Genes Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America CRISPR and CRISPR-associated (Cas) Genes Market Analysis

    • 7.1 North America CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 7.2 North America CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    • 7.3 North America CRISPR and CRISPR-associated (Cas) Genes Market Analysis and Forecast, by Country

      • 7.3.1 United States CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe CRISPR and CRISPR-associated (Cas) Genes Market Analysis

    • 8.1 Europe CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 8.2 Europe CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    • 8.3 Europe CRISPR and CRISPR-associated (Cas) Genes Market Analysis and Forecast, by Country

      • 8.3.1 Germany CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC CRISPR and CRISPR-associated (Cas) Genes Market Analysis

    • 9.1 APAC CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 9.2 APAC CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    • 9.3 APAC CRISPR and CRISPR-associated (Cas) Genes Market Analysis and Forecast, by Country

      • 9.3.1 China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Market Analysis

    • 10.1 Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Market, by Type

    • 10.2 Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Market, by Application

    • 10.3 Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China CRISPR and CRISPR-associated (Cas) Genes Company Profiles

      • 11.1 GE Healthcare Dharmacon

        • 11.1.1 GE Healthcare Dharmacon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 GE Healthcare Dharmacon CRISPR and CRISPR-associated (Cas) Genes Product Profiles, Application and Specification

        • 11.1.3 GE Healthcare Dharmacon CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Intellia Therapeutics

        • 11.2.1 Intellia Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Intellia Therapeutics CRISPR and CRISPR-associated (Cas) Genes Product Profiles, Application and Specification

        • 11.2.3 Intellia Therapeutics CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Addgene

        • 11.3.1 Addgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Addgene CRISPR and CRISPR-associated (Cas) Genes Product Profiles, Application and Specification

        • 11.3.3 Addgene CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Caribou Biosciences

        • 11.4.1 Caribou Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Caribou Biosciences CRISPR and CRISPR-associated (Cas) Genes Product Profiles, Application and Specification

        • 11.4.3 Caribou Biosciences CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Editas Medicine

        • 11.5.1 Editas Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Editas Medicine CRISPR and CRISPR-associated (Cas) Genes Product Profiles, Application and Specification

        • 11.5.3 Editas Medicine CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Takara Bio USA

        • 11.6.1 Takara Bio USA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Takara Bio USA CRISPR and CRISPR-associated (Cas) Genes Product Profiles, Application and Specification

        • 11.6.3 Takara Bio USA CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Thermo Fisher Scientific

        • 11.7.1 Thermo Fisher Scientific Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Thermo Fisher Scientific CRISPR and CRISPR-associated (Cas) Genes Product Profiles, Application and Specification

        • 11.7.3 Thermo Fisher Scientific CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Merck KGaA

        • 11.8.1 Merck KGaA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Merck KGaA CRISPR and CRISPR-associated (Cas) Genes Product Profiles, Application and Specification

        • 11.8.3 Merck KGaA CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Mirus Bio LLC

        • 11.9.1 Mirus Bio LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Mirus Bio LLC CRISPR and CRISPR-associated (Cas) Genes Product Profiles, Application and Specification

        • 11.9.3 Mirus Bio LLC CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 CRISPR THERAPEUTICS

        • 11.10.1 CRISPR THERAPEUTICS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 CRISPR THERAPEUTICS CRISPR and CRISPR-associated (Cas) Genes Product Profiles, Application and Specification

        • 11.10.3 CRISPR THERAPEUTICS CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Horizon Discovery Group

        • 11.11.1 Horizon Discovery Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Horizon Discovery Group CRISPR and CRISPR-associated (Cas) Genes Product Profiles, Application and Specification

        • 11.11.3 Horizon Discovery Group CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 CRISPR and CRISPR-associated (Cas) Genes Industry Investment Prospect and Risk Assessment

    • 12.1 CRISPR and CRISPR-associated (Cas) Genes Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 CRISPR and CRISPR-associated (Cas) Genes Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Production Value and Growth Rate (2017-2028)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production Value and Growth Rate (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Genome Editing (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Genetic Engineering (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of gRNA Database/Gene Librar (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of CRISPR Plasmid (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Human Stem Cells (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Genetically Modified Organisms/Crops (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Cell Line Engineering (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Biotechnology Companies (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Pharmaceutical Companies (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Academic Institutes (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Market Size and Growth Rate of Research and Development Institutes (2017-2028)

    • Figure North America CRISPR and CRISPR-associated (Cas) Genes Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe CRISPR and CRISPR-associated (Cas) Genes Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC CRISPR and CRISPR-associated (Cas) Genes Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China CRISPR and CRISPR-associated (Cas) Genes Sales Value, by Manufacturer (2021&2022)

    • Table Global and China CRISPR and CRISPR-associated (Cas) Genes Market Share, by Manufacturer (2021&2022)

    • Figure Global and China CRISPR and CRISPR-associated (Cas) Genes Market Share, by Manufacturer in 2021

    • Figure Global and China CRISPR and CRISPR-associated (Cas) Genes Market Share, by Manufacturer in 2022

    • Table Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Type (2017-2028)

    • Table Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Table Global CRISPR and CRISPR-associated (Cas) Genes Sales Value, by Type (2017-2028)

    • Table Global CRISPR and CRISPR-associated (Cas) Genes Sales Value Share, by Type (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Price Trend, by Type (2017-2028)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Type (2017-2028)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Value, by Type (2017-2028)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Value Share, by Type (2017-2028)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Price Trend, by Type (2017-2028)

    • Table Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Application (2017-2028)

    • Table Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Table Global CRISPR and CRISPR-associated (Cas) Genes Sales Value, by Application (2017-2028)

    • Table Global CRISPR and CRISPR-associated (Cas) Genes Sales Value Share, by Application (2017-2028)

    • Figure Global CRISPR and CRISPR-associated (Cas) Genes Sales Value Share, by Application (2017-2028)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Application (2017-2028)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Value, by Application (2017-2028)

    • Table China CRISPR and CRISPR-associated (Cas) Genes Sales Value Share, by Application (2017-2028)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Value Share, by Application (2017-2028)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Production, Import, Consumption and Export (2017-2022)

    • Figure North America CRISPR and CRISPR-associated (Cas) Genes Production, Import, Consumption and Export (2017-2022)

    • Figure Europe CRISPR and CRISPR-associated (Cas) Genes Production, Import, Consumption and Export (2017-2022)

    • Figure APAC CRISPR and CRISPR-associated (Cas) Genes Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Production, Import, Consumption and Export (2017-2022)

    • Table North America CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Type (2017-2028)

    • Table North America CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Figure North America CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Table North America CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Application (2017-2028)

    • Table North America CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Figure North America CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Figure United States CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure United States CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Canada CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Canada CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Mexico CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Table Europe CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Type (2017-2028)

    • Table Europe CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Figure Europe CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Table Europe CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Application (2017-2028)

    • Table Europe CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Figure Europe CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Figure Germany CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Germany CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure UK CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure UK CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure France CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure France CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Italy CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Italy CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Spain CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Spain CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Belgium CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Poland CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Poland CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Russia CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Russia CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Turkey CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Table APAC CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Type (2017-2028)

    • Table APAC CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Figure APAC CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Table APAC CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Application (2017-2028)

    • Table APAC CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Figure APAC CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure China CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Japan CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Japan CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure India CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure India CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure South Korea CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa CRISPR and CRISPR-associated (Cas) Genes Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Brazil CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure South Africa CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Figure Argentina CRISPR and CRISPR-associated (Cas) Genes Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina CRISPR and CRISPR-associated (Cas) Genes Sales Value and Growth Rate (2017-2028)

    • Table GE Healthcare Dharmacon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GE Healthcare Dharmacon Product Profiles, Application and Specification

    • Table GE Healthcare Dharmacon CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Intellia Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Intellia Therapeutics Product Profiles, Application and Specification

    • Table Intellia Therapeutics CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Addgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Addgene Product Profiles, Application and Specification

    • Table Addgene CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Caribou Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Caribou Biosciences Product Profiles, Application and Specification

    • Table Caribou Biosciences CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Editas Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Editas Medicine Product Profiles, Application and Specification

    • Table Editas Medicine CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takara Bio USA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takara Bio USA Product Profiles, Application and Specification

    • Table Takara Bio USA CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Thermo Fisher Scientific Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Thermo Fisher Scientific Product Profiles, Application and Specification

    • Table Thermo Fisher Scientific CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck KGaA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck KGaA Product Profiles, Application and Specification

    • Table Merck KGaA CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mirus Bio LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mirus Bio LLC Product Profiles, Application and Specification

    • Table Mirus Bio LLC CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CRISPR THERAPEUTICS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CRISPR THERAPEUTICS Product Profiles, Application and Specification

    • Table CRISPR THERAPEUTICS CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Horizon Discovery Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Horizon Discovery Group Product Profiles, Application and Specification

    • Table Horizon Discovery Group CRISPR and CRISPR-associated (Cas) Genes Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US